We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

47 hedge funds and large institutions have $409M invested in Stoke Therapeutics in 2019 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

45.24% more ownership

Funds ownership: 0% → 45.24% (+45%)

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$90.1M
2
CAM
Cormorant Asset Management
Massachusetts
+$50.2M
3
GGHC
Gilder Gagnon Howe & Co
New York
+$50M
4
RCM
RA Capital Management
Massachusetts
+$30.1M
5
RG
Redmile Group
California
+$27.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$1.06M +$976K +36,355 New
GPCM
27
Granite Point Capital Management
Massachusetts
$992K +$913K +34,000 New
LCM
28
Laurion Capital Management
New York
$729K +$671K +25,000 New
Norges Bank
29
Norges Bank
Norway
$729K +$671K +25,000 New
SC
30
Sculptor Capital
New York
$729K +$671K +25,000 New
ZP
31
Zimmer Partners
New York
$729K +$671K +25,000 New
DIM
32
DC Investments Management
Virginia
$684K +$630K +23,464 New
Blackstone Inc
33
Blackstone Inc
New York
$598K +$550K +20,500 New
SM
34
Sabby Management
Florida
$473K +$435K +16,202 New
SG Americas Securities
35
SG Americas Securities
New York
$391K +$360K +13,400 New
KC
36
KCL Capital
New York
$292K +$269K +10,000 New
BCM
37
BlueCrest Capital Management
Jersey
$230K +$212K +7,891 New
Tudor Investment Corp
38
Tudor Investment Corp
Connecticut
$219K +$201K +7,500 New
FAM
39
Fred Alger Management
New York
$146K +$134K +5,000 New
Morgan Stanley
40
Morgan Stanley
New York
$104K +$95.3K +3,550 New
LTFS
41
Ladenburg Thalmann Financial Services
Florida
$88K +$80.6K +3,000 New
Victory Capital Management
42
Victory Capital Management
Texas
$73K +$67.1K +2,500 New
UBS Group
43
UBS Group
Switzerland
$44K +$40.8K +1,520 New
AAMU
44
Amundi Asset Management US
Massachusetts
$29K +$26.9K +1,000 New
PIM
45
Platinum Investment Management
Australia
$29K +$26.9K +1,000 New
Barclays
46
Barclays
United Kingdom
$27K +$24.5K +914 New
CCA
47
Catalyst Capital Advisors
New York
$7K +$6.45K +240 New
1
2

STOK Hedge Fund Activity: Q2 2019 in Review

47 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q2 2019, worth a combined $409M.

Buyers outnumbered sellers: 47 funds opened new STOK positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $90.1M.

  • 47 institutional investors held Stoke Therapeutics (STOK) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $409M of Stoke Therapeutics stock for Q2 2019.
  • 47 funds opened new Stoke Therapeutics positions in Q2 2019 and 0 closed out, a net change of +47 holders.
  • The largest Stoke Therapeutics buyer in Q2 2019 was RTW Investments, an estimated $90.1M added.

Based on aggregated 13F filings for Q2 2019.